Semnur Pharmaceuticals, Inc. (SMNR)
OTCMKTS · Delayed Price · Currency is USD
18.00
+4.00 (28.57%)
At close: Dec 16, 2025

Semnur Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
4,5953972111
Market Cap Growth
3802.22%-45.38%-35.07%-
Enterprise Value
4,60581--
Last Close Price
20.0011.8810.1710.29
PB Ratio
-314.86-0.92-1.90-3.20
Debt / Equity Ratio
-0.67-1.15-0.99-1.02
Quick Ratio
0.010.340.010.14
Current Ratio
0.01171.290.020.37
Return on Assets (ROA)
--79.36%-278.24%-
Return on Capital (ROIC)
--90.81%-1089.91%-
Return on Capital Employed (ROCE)
1674.60%-70.50%1689.60%-664.00%
Earnings Yield
-3.37%-11.88%-4.51%-3.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.